Ultomiris (Ravulizumab Vials) 300mg/30ml

Ultomiris (ravulizumab) is a monoclonal antibody infusion used for rare blood disorders like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Administered by healthcare professionals, it helps manage symptoms and reduce complications. Search for 'buy Ultomiris online' for availability.

Strength

300mg/30ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Alexion

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ravulizumab (Ultomiris) is prescribed to treat rare blood disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). These conditions involve the destruction of red blood cells, leading to anemia and other complications. The medication works by targeting specific proteins in the immune system to reduce abnormal blood cell destruction. It is typically used when other treatments are ineffective or unsuitable.

Side Effects

Ultomiris helps reduce the need for blood transfusions and may improve symptoms like fatigue and shortness of breath. Patients often report a reduction in complications related to their condition, such as blood clots or kidney issues. Regular monitoring is required to assess response and adjust treatment as needed.

Precautions & Warnings

Ultomiris is administered under medical supervision due to the risk of serious infections and infusion reactions. Patients should inform their healthcare provider of any infections, fever, or recent vaccinations before starting treatment. Pregnant or breastfeeding individuals should discuss risks with their doctor, as the effects on unborn children or infants are not fully known.

Avoid Interactions

Ravulizumab may interact with vaccines, particularly live vaccines, which should be avoided during treatment. Certain medications, such as immunosuppressants or blood thinners, may require dose adjustments or monitoring. Always disclose all medications and supplements to your healthcare provider to minimize potential interactions.

Frequently Asked Questions

Ultomiris (ravulizumab) is used to treat rare blood disorders like PNH and aHUS by reducing abnormal blood cell destruction.

It is given as an infusion by a healthcare professional, typically in a clinical setting.

Availability varies; consult a licensed pharmacy or healthcare provider for prescription and supply options.

Common effects may include headache, diarrhea, or infusion-related reactions; discuss concerns with your doctor.

Its safety in pregnancy is not fully established; consult your healthcare provider to weigh potential risks and benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.